Literature DB >> 19626049

Imatinib mesylate causes growth plate closure in vivo.

K Vandyke, A L Dewar, S Fitter, D Menicanin, L B To, T P Hughes, A C W Zannettino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19626049     DOI： 10.1038/leu.2009.150

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood.

Authors:  Hong Hoe Koo
Journal:  Korean J Pediatr       Date:  2011-03-31

2.  Automated volumetric growth plate measurement using magnetic resonance imaging for monitoring skeletal toxicity in children treated on investigational drug trials.

Authors:  AeRang Kim; Eva Dombi; Jeffrey Solomon; Elizabeth Fox; Frank M Balis; Brigitte C Widemann
Journal:  Clin Cancer Res       Date:  2011-08-01       Impact factor: 12.531

Review 3.  Endocrine side effects of broad-acting kinase inhibitors.

Authors:  Maya B Lodish; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

Review 4.  Clinical review: kinase inhibitors: adverse effects related to the endocrine system.

Authors:  Maya B Lodish
Journal:  J Clin Endocrinol Metab       Date:  2013-02-28       Impact factor: 5.958

Review 5.  Targeting developmental pathways in children with cancer: what price success?

Authors:  Lia Gore; James DeGregori; Christopher C Porter
Journal:  Lancet Oncol       Date:  2013-02       Impact factor: 41.316

Review 6.  Chronic Myelogenous Leukemia in Childhood.

Authors:  Stephanie M Smith; Nobuko Hijiya; Kathleen M Sakamoto
Journal:  Curr Oncol Rep       Date:  2021-03-14       Impact factor: 5.075

7.  The treatment of pediatric chronic myelogenous leukemia in the imatinib era.

Authors:  Jae Wook Lee; Nack Gyun Chung
Journal:  Korean J Pediatr       Date:  2011-03-31

8.  The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation.

Authors:  K Vandyke; S Fitter; A C W Zannettino
Journal:  Blood Cancer J       Date:  2011-02-04       Impact factor: 11.037

9.  Impact of long-term exposure to the tyrosine kinase inhibitor imatinib on the skeleton of growing rats.

Authors:  Josephine T Tauer; Lorenz C Hofbauer; Roland Jung; Sebastian Gerdes; Ingmar Glauche; Reinhold G Erben; Meinolf Suttorp
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

10.  The teratogenic effects of imatinib mesylate on rat fetuses.

Authors:  M M El Gendy; A M Kandil; M A Helal; F M Zahou
Journal:  Toxicol Rep       Date:  2015-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.